Chikalthana L-1OVERVIEW
| Established in the year: | 1979 |
| Facility Area: | 24,000
m2 | | Formulation
mfg area: | 12,000 m2 | | API
manufacturing area: | 1,709 m2 |
| Dosage form: | Tablets
Capsules
Powder & dry suspensions
Sterile injectables (ampoules
& vials) | | Regulatory
approval: | USFDA / MHRA |
Wockhardt's Chikalthana facility, India, is one of our oldest and most established
facilities within our network, which offers full commercial manufacturing services
for conventional solid and sterile liquid forms. With our aseptic liquids capacity
we can offer a range of sizes for glass vials and ampoules. The facilities solid
dose capabilities include standard, sugar and film coated tablets whilst also
offering hard gelatine capsules that are packed in blister or bottle formats.
Chikalthana is also able to offer powder and dry suspension capacity into bottles
and also boasts API manufacturing capabilities.
Qualified Persons are
able to release product, for European and US markets, through our Wockhardt UK
facility. | 
